Statistics for Anavex Life Sciences (id:7926 AVXL)
Valuation metrics
Market cap
631.30M
Enterprise value
492.55M
Trailing P/E (ttm)
-15.18
Forward P/E
-11.82
PEG ratio
-11.82
Price/Sales (ttm)
Price/Book (mrq)
4.86
Enterprise Value/Revenue
Enterprise Value/EBITDA
-10.59
Overview
Shares outstanding
84.80M
Float
82.21M
Shares short
18.31M
% Held by insiders
0.03%
% Held by institutions
0.32%
Average volume (10 days)
1.88M
Average volume (90 days)
Price summary
52-Week low
3.25
52-Week high
10.45
52-Week change
30.19%
Beta
0.60
50-Day moving average
6.07
200-Day moving average
5.23
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
October 07th, 2015
Financials
Fiscal yearFiscal year ends
September 30th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-20.43%
Return on equity
-30.03%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-41,528,000.00
Diluted EPS (ttm)
-0.51
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
138.76M
Total cash per share (mrq)
1.64
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
1.20K%
Book value per share (mrq)
1.53
Cash flow
Cash flow statement
-30,003,000.00
Levered free cash flow (LFCF)
-19,058,068.00